Adams Catherine Owen 4
4 · ACADIA PHARMACEUTICALS INC · Filed Sep 25, 2024
Insider Transaction Report
Form 4
Owen Adams Catherine
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-23+353,261→ 353,261 totalExercise: $16.29Exp: 2034-09-22→ Common Stock (353,261 underlying)
Footnotes (2)
- [F1]The Stock Option has been granted pursuant to the Issuer's 2024 Inducement Plan as a material inducement to the reporting person's acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
- [F2]25% of the shares subject to the Stock Option will vest and become exercisable on September 23, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.